Erythromycin treatment suppresses myocardial injury in autoimmune myocarditis in rats via suppression of superoxide production

International Journal of Cardiology

Volumn 167, Issue 5, 2013, Pages 2228-2233

  Hirano, Emi ^a   Shimada, Kana ^a   Komiyama, Taeka ^a   Fujita, Masatoshi ^a   Kishimoto, Chiharu ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

14 member ring macrolides; Autoimmune myocarditis; Erythromycin; Superoxide production

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; ERYTHROMYCIN; HYDROETHIDINE; INTERLEUKIN 1BETA; MYOSIN; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; BODY WEIGHT; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG MECHANISM; ECHOCARDIOGRAPHY; HEART FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE INJURY; HISTOPATHOLOGY; IN VIVO STUDY; MACROPHAGE MIGRATION; MALE; MYOCARDITIS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; WESTERN BLOTTING;

14-MEMBER RING MACROLIDES; AUTOIMMUNE MYOCARDITIS; ERYTHROMYCIN; SUPEROXIDE PRODUCTION;

ANIMALS; AUTOIMMUNE DISEASES; ERYTHROMYCIN; MYOCARDITIS; RATS; RATS, INBRED LEW; SUPEROXIDES; SWINE; TREATMENT OUTCOME;

EID: 84883306438     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.06.014     Document Type: Article

References (28)

1. C. Kawai From myocarditis to cardiomyopathy. Mechanisms of inflammation and cell death. Learning from the past for the future Circulation 99 1999 1091 1100
2. M. Kodama, Y. Matsumoto, M. Fujiwara, F. Masani, T. Izumi, and A. Shibata A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction Clin Immunol Immunopathol 57 1990 250 262
3. C.C. Lin, S.F. Liaw, K.M. Wu, and C.H. Lin Effect of erythromycin on bronchial hyperreactivity and inflammation in ovalbumin-sensitized brown Norway rats Respir Physiol Neurobiol 161 2008 267 272
4. M. Shinkai, G.H. Foster, and B.K. Rubin Macrolide antibiotics modulate ERK phosphorylation and IL-8 and GM-CSF production by human bronchial epithelial cells Am J Physiol 290 2006 L75 L85
5. S. Paju, P.J. Pussinen, and J. Sinisalo Clarithromycin reduces recurrent cardiovascular events in subjects without periodontitis Atherosclerosis 188 2006 412 419
6. K. Morikawa, F. Oseko, S. Morikawa, and K. Iwamoto Immunomodulatory effects of three macrolides, midecamycin acetate, josamycin, and clarithromycin, on human T-lymphocyte function in vitro Antimicrob Agents Chemother 38 1994 2643 2647
7. 1 antagonist, suppresses cytotoxic myocardial injury in autoimmune heart failure Am J Physiol 289 2005 H1147 H1152
8. K. Shioji, C. Kishimoto, and S. Sasayama Fc receptor-mediated inhibitory effect of immunoglobulin therapy on autoimmune giant cell myocarditis. Concomitant suppression of the expression of dendritic cells Circ Res 89 2001 540 546
9. Z. Yuan, C. Kishimoto, and K. Shioji Beneficial effects of low dose benedipine in acute autoimmune myocarditis. Suppressive effects on inflammatory cytokines and inducible nitric oxide synthase Circ J 67 2003 545 550
10. Z. Yuan, K. Shioji, Y. Kihara, H. Takenaka, Y. Onozawa, and C. Kishimoto Cardioprotective effects of carvedilol on acute autoimmune myocarditis. Anti-inflammatory effects associated with antioxidant property Am J Physiol 286 2004 H83 H90
11. K. Shimada, T.A. Okabe, Y. Mikami, M. Hattori, M. Fujita, and C. Kishimoto Therapy with granulocyte colony-stimulating factor in the chronic stage, but not in the acute stage, improves experimental autoimmune myocarditis in rats via nitric oxide J Mol Cell Cardiol 49 2010 469 481
12. K. Shimada, T. Murayama, and M. Yokode N-acetylcysteine reduces the severity of atherosclerosis in apolipoprotein E-deficient mice by reducing superoxide production Circ J 73 2009 1337 1341
13. K. Shimada, T. Murayama, M. Yokode, T. Kita, M. Fujita, and C. Kishimoto Olmesartan, a novel angiotensin II type 1 receptor antagonist, reduces severity of atherosclerosis in apolipoprotein E deficient mice associated with reducing superoxide production Nutr Metab Cardiovasc Dis 21 2010 672 678
14. K. Shimada, Y. Mikami, and T. Murayama Atherosclerotic plaques induced by marble-burying behavior are stabilized by exercise training in experimental atherosclerosis Int J Cardiol 151 2010 284 289
15. W. Liu, H. Nakamura, and K. Shioji Thioredoxin-1 ameliorates myosin-induced autoimmune myocarditis by suppressing chemokine expressions and leukocyte chemotaxis in mice Circulation 110 2004 1276 1283
16. C. Kishimoto, H. Takada, H. Kawamata, M. Umatake, and H. Ochiai Immunoglobulin treatment prevents congestive heart failure in murine encephalomyocarditis viral myocarditis associated with reduction of inflammatory cytokines J Pharmacol Exp Ther 299 2001 645 651
17. T. Kubota, C.F. McTiernan, C.S. Frye, A.J. Demetris, and A.M. Feldman Cardiac-specific overexpression of tumor necrosis factor-alpha causes lethal myocarditis in transgenic mice J Card Fail 3 1997 117 124
18. C. Kishimoto, N. Takamatsu, H. Kawamata, H. Shinohara, and H. Ochiai Immunoglobulin treatment ameliorates murine myocarditis with reduction of neurohumoral activity and improvement of extracellular matrix J Am Coll Cardiol 36 2000 1979 1984
19. K. Shioji, C. Kishimoto, and H. Nakamura Overexpression of thioredoxin-1 in transgenic mice attenuates adriamycin-induced cardiotoxicity Circulation 106 2002 1403 1409
20. J. Suzuki, M. Ogawa, H. Futamatsu, H. Kosuge, H. Tanaka, and M. Isobe A cyclooxygenase-2 inhibitor alters Th1/Th2 cytokine balance and suppresses autoimmune myocarditis in rats J Mol Cell Cardiol 40 2006 688 695
21. C. Kishimoto, T.A. Okabe, M. Hattori, and Z. Yuan Naloxone, an opiate receptor antagonist, ameliorates acute experimental autoimmune myocarditis by reducing cytotoxic activities J Cardiovasc Pharmacol 52 2008 445 451
22. Q. Li, and I.M. Verma NF-kappaB regulation in the immune system Nat Rev Immunol 2 2002 725 734
23. M. Ogawa, J. Suzuki, K. Hishikari, K. Takayama, H. Tanaka, and M. Isobe Clarithromycin attenuates acute and chronic rejection via matrix metalloproteinase suppression in murine cardiac transplantation J Am Coll Cardiol 51 2008 1977 1985
24. N. Hashimoto, T. Kawabe, and T. Hara Effect of erythromycin on matrix metalloproteinase-9 and cell migration J Lab Clin Med 137 2001 176 183
25. S. Ohshima, S. Fujimoto, and A. Petrov Effect of an antimicrobial agent on atherosclerotic plaques. Assessment of metalloproteinase activity by molecular imaging J Am Coll Cardiol 55 2010 1240 1249
26. G.F. Nieman, and B.R. Zerler A role for the anti-inflammatory properties of tetracyclines in the prevention of acute lung injury Curr Med Chem 8 2001 317 325
27. A.N. Sapadin, and R. Fleischmajer Tetracychines. Nonantibiotic properties and their clinical implications J Am Acad Dermatol 54 2006 258 265
28. K. Hishikari, R. Watanabe, and M. Ogawa Early treatment with clarithromycin attenuates rat autoimmune myocarditis via inhibition of matrix metalloproteinase activity Heart 96 2010 523 527